Effect of an Ulva lactuca Extract on Systemic Antioxidant and Inflammatory Biomarkers in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients · 2026
DOI: 10.3390/nu18142244 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Ralf Jäger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Increnovo LLC, Whitefish Bay, WI 53217, USA. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Antioxidants, Inflammation, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BluGen LLC.
Abstract (Originalsprache)
Background
Ulva lactuca (sea lettuce) is a green macroalgae rich in sulfated polysaccharides (ulvans), polyphenols, and pigments with documented antioxidant and anti-inflammatory activity in preclinical models. Translational human data remain limited.
Methods
Twenty healthy adults (20–35 years; BMI 18.5–30 kg/m2) were enrolled in a single-center, randomized, double-blind, placebo-controlled, parallel-group trial (CTRI/2025/11/097278) and assigned 1:1 to receive 300 mg of an U. lactuca extract or matched placebo once daily for 28 days. Antioxidant biomarkers (GSH, MDA, catalase, GPx-1, thioredoxin) and inflammatory biomarkers (CRP, IL-6, IL-1β, IL-11, PPAR-γ) were measured at Day 0 and Day 28. Safety was assessed throughout.
Results
Eighteen of 20 participants completed the study. Compared with placebo, U. lactuca produced significant within-group improvements at Day 28 in GSH (+4.04 ng/mL), GPx-1 (+67.8 µU/mL), and catalase (+32.4 kU/L) and reductions in MDA (−6.08 nmol/mL) and thioredoxin (−1.48 ng/mL); inflammatory markers CRP (−0.91 mg/L), IL-6 (−2.97 pg/mL), IL-11 (−4.28 ± 1.88 ng/mL) and IL-1β (−8.87 pg/mL) decreased and PPAR-γ increased.
Conclusions
In this short-duration pilot trial, daily supplementation with 300 mg of an U. lactuca extract was well tolerated and modulated systemic oxidative-stress and low-grade inflammatory biomarkers in healthy adults. Larger and longer studies in populations with elevated oxidative stress are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Increnovo LLC, Whitefish Bay, WI 53217, USA.
- Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
- Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.
- Radiant Research Services Pvt. Ltd., Bangalore 560058, India.
- BluGen LLC, Boca Raton, FL 33432, USA.
- Human Performance Laboratory, Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL 33606, USA.
ORCID-Profile: Ralf Jäger, Martin Purpura, Ashok Godavarthi
Förderung
- BluGen LLC
Zitieren
APA
Jäger, R., Luesch, H., Purpura, M., Godavarthi, A., Balcombe, S. T., & Vasenina, E. (2026). Effect of an Ulva lactuca Extract on Systemic Antioxidant and Inflammatory Biomarkers in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu18142244
Vancouver
Jäger R, Luesch H, Purpura M, Godavarthi A, Balcombe ST, Vasenina E. Effect of an Ulva lactuca Extract on Systemic Antioxidant and Inflammatory Biomarkers in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2026. doi:10.3390/nu18142244
BibTeX
@article{Jger2026,
author = {Jäger, Ralf and Luesch, Hendrik and Purpura, Martin and Godavarthi, Ashok and Balcombe, Sebastian T and Vasenina, Ecaterina},
title = {Effect of an Ulva lactuca Extract on Systemic Antioxidant and Inflammatory Biomarkers in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18142244}
}
EUVIMED